Skip to content

Part of the World CNS Series: World CNS | Neuroimmunology Drug Development | Neuromuscular Drug Development | Neuropsychiatry Drug Development | Neurodegenerative Drug Development Europe | Blood-Brain Barrier Drug Delivery | Gene Therapy for Neurological Disorders

HW190627 GTxN Gene Therapy for Neurological Disorders logo FINAL

December 10-12
Boston, MA

Overcoming the translational challenges for gene
therapies targeting neurological disorders

  • Home
  • About
    • About Event
    • Exclusive Content
    • Full Event Guide
    • Speakers
    • Agenda
      • Pre-Conference Workshops
      • Conference Day One
      • Conference Day Two
    • Venue
    • Accommodation
  • Partner
    • Partnership Opportunities
    • 2019 Partners
  • Get Involved
    • Pricing
    • Register
    • Contact us
About › Venue
  • About Event
  • Full Event Guide
  • Exclusive Content
  • Speakers
  • Agenda
  • Pre-Conference Workshops
  • Conference Day One
  • Conference Day Two
  • Venue
  • Accommodation
Secure Your Place (1)

Venue

Gene Therapy for Neurological Disorders will be held at

The Colonnade Hotel
120 Huntington Ave
Boston, MA
02116
United States

(617) 424-7000
www.colonnadehotel.com
Colonnade 3
Colonnade 2
Colonnade hotel
Next Page: AccommodationClick Here >

OUR CONTACT DETAILS

T: (+1) 617 455 4188
E: info@hansonwade.com

VENUE DETAILS

The Colonnade Hotel
120 Huntington Ave
Boston, MA
02116
United States

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

LOCATION

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok